JPRN-UMIN000054003尚未招募Unknown
A Retrospective Chart Review: Current Status of Patients with Borderline Personality Disorder (BPD) and Medical Care in Japan - Chart Review for BPD in Japan
ippon Boehringer Ingelheim Co., Ltd. (NBI: Sponsor)0 个研究点目标入组 80 人开始时间: 2024年4月12日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with BPD who see the physicians planning this study, including Boehringer Ingelheim Co., Ltd. Employees, the members of the steering committee and advisors 2)Patients who had participated in research studies involving interventions during the target period of data collection 3)Patients judged to be inappropriate by the principal investigator or sub-investigator for some reasons
研究者
相似试验
已完成
不适用
Retrospective and prospective evaluation of the pharmacogenetics and metabolites of thiopurine drugs in the treatment of inflammatory bowel diseaseInflammatory bowel diseaseDigestive SystemOther noninfective gastroenteritis and colitisISRCTN58287360Sun Yat-sen University (China)170
已完成
不适用
Cross-sectional study on the current status of palliative care in dermato-oncologyC44Other malignant neoplasms of skinDRKS00029195niversitätsklinikum MarburgKlinik für Dermatologie und AllergologieHauttumorzentrum45
已完成
不适用
Cross-sectional study on the current status of the activity of death doulas in the support of dying people in Germanyend-of-life careDRKS00030426Klinik für Anästhesie und IntensivmedizinUniversitätsklinikum Gießen und MarburgStandort Marburg339
已完成
不适用
Herbal decoction in allergic rhinitis: Chart reviewKCT0007242Korea Institute of Oriental Medicine178
进行中（未招募）
1 期
A PROSPECTIVE, OPEN-LABEL STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY & EFFICACY OF ANIDULAFUNGIN WHEN USED TO TREAT CHILDREN WITH INVASIVE CANDIDIASIS, INCLUDING CANDIDEMIA - NDEUCTR2008-004150-32-ITPFIZER60